Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Letrozole

A non-steroidal inhibitor of aromatase, the enzyme that makes oestrogens: patented in 1986 and approved in 1996, it is used against hormone-sensitive breast cancer in postmenopausal women. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?By lowering oestrogen it prompts the pituitary to release more follicle-stimulating hormone: for this reason, since the early 2000s, it has also been studied and used to induce ovulation in polycystic ovary syndrome.

LetrozoleGo to the active ingredient →
LetrozoleActive ingredientLetrozoleCat. No. P-L038-001CAS 112809-51-5
Letrozole-d4Isotopically labelledLetrozole-d4Cat. No. P-L038-005CAS 1133712-96-5

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Reference substanceLetrozole CRSEDQM code Y0000685Family Letrozole

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.